Moreover, according to AFP concentrations used for decision-making regarding HCC diagnosis, the frequency of GA+AA carriers was higher among those with AFP ≤ 20 ng/ml or ≤400 ng/ml than among individuals with AFP > 20 ng/ml or >400 ng/ml. This evidence concerns the gene AFP and hepatocellular carcinoma.